Nanomedicines modulate the tumor immune microenvironment for cancer therapy

Po-Han Chao,Vanessa Chan,Shyh-Dar Li
DOI: https://doi.org/10.1080/17425247.2024.2412245
2024-10-05
Expert Opinion on Drug Delivery
Abstract:Introduction In recent years, the evolution of immunotherapy as a means to trigger a robust antitumor immune response has revolutionized cancer treatment. Despite its potential, the effectiveness of cancer immunotherapy is hindered by low response rates and significant systemic side effects. Nanotechnology emerges as a promising frontier in shaping the future of cancer immunotherapy.
pharmacology & pharmacy
What problem does this paper attempt to address?